[Congenital atrioventricular block and maternal autoimmune diseases].
Congenital heart block is rare; it is acquired in utero, definitive and, more often than not, complete. It can be diagnosed by the appearance of fetal bradycardia around the 23rd week of gestation, during ultrasonographic monitoring of pregnancy. Heart block is usually associated with the presence of anti-Ro and/or anti-La antibodies in the mother's serum. These maternal immunological abnormalities can be isolated or associated with an autoimmune disease, usually systemic lupus erythematosus, but also Sjögren's syndrome, or more rarely still, an as yet unclassified connective tissue disease. Anti-Ro and anti-La antibodies cross the placental barrier and react with a fetal heart, leading to acute fetal myocarditis by the 17th week of gestation. When severe, it is lethal, otherwise it can result in degeneration and endocardial fibroelastosis, disrupting conduction and leading to congenital heart block. The ideal treatment would be prevention with corticosteroids. When the mother is Ro or La antibody-positive before pregnancy, elimination of these circulating antibodies can be attempted by treatment with 0.5 mg/kg body wt/d of prednisolone for 3 months. If the treatment is successful, corticotherapy can be prescribed early in the pregnancy to try to protect the fetus. However, there is not always a relationship between maternal anti-Ro antibodies and fetal heart block. If the Ro/La antibody-positive woman is already pregnant, but before her 17th week, it is possible to prescribe dexamethasone, which crosses the placenta and remains active, sometimes in association with plasmapheresis.
Herreman
G
G
Service de Médecine Interne, Hôpital Saint-Joseph, Paris.
Sauvaget
F
F
Généreau
T
T
Galezowski
N
N
D000974:Antibodies, Antinuclear / Q000502:physiology; D001327:Autoimmune Diseases / Q000628:therapy; D005260:Female; D006327:Heart Block / Q000151:congenital* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D008180:Lupus Erythematosus, Systemic / Q000151:congenital / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy
D000974:Antibodies, Antinuclear; C035356:SS-A antibodies; C035357:SS-B antibodies
Blocs auriculo-ventriculaires congénitaux et maladies auto-immunes maternelles.